ArticleBMC psychiatry2025
Investigating the psychometric properties of the Premenstrual Symptoms Screening Tool (PSST) among Bangladeshi adolescent girls.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective.Journal of clinical medicine · 2026Review
- Structural equation modeling of the effect of childhood trauma on premenstrual syndrome: the mediating role of rumination in adolescent girls.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPremenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) affect many reproductive-aged women and can significantly impact their quality of life, including academic performance, relationships, and mental health, perhaps even leading to suicidal behavior. However, there was no validated, robust, and psychometrically sound instrument to screen for symptoms in the Bangladeshi context. This study aimed to translate and adapt a widely used instrument, the Premenstrual Symptoms Screening Tool (PSST) in the Bangladeshi context, and to assess the prevalence of PMS and PMDD among adolescent girls in Bangladesh. METHODOLOGY: A cross-sectional study was conducted among 939 adolescent girls in Bangladesh aged 11-19 years using the "Konnect" platform of a2i between April to October 2022. Data were collected through a pre-tested semi-structured questionnaire that included informed consent, socio-demographic information, menstrual history, the Depression Anxiety and Stress Scale 21 (DASS-21), and the PSST scale. Statistical analysis, including descriptive statistics and confirmatory factor analysis, was performed using IBM SPSS Statistics (version 25.0) and IBM SPSS Amos (version 26.0). Convergent validity was assessed by correlating the Bangla version of the PSST with depression, anxiety, and stress subscales of the DASS-21.
resultsThe prevalence estimates of moderate to severe PMS and PMDD were 33.16%, and 19.05%, respectively. Item-level analysis showed that the measurement items were normally distributed which suggested measurement of the same construct. The Bangla version of the PSST demonstrated excellent internal consistency (Cronbach alpha = 0.96) and convergent validity. The total PSST score was positively and significantly correlated with depression (r = 0.54), anxiety (r = 0.50), and stress (r = 0.50), suggesting convergent validity. The scale-level psychometric properties were satisfactory, indicating an excellent fit to the data and supporting convergent validity.
conclusionsThe Bangla version of the PSST was found to be a valid screening tool for assessing PMS in women in Bangladesh. It will help to identify and address their healthcare needs, promote well-being, and advance further research in the Bangladeshi context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.